Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abo El Ola, S. M., R. Kotek, et al. (2004). “Studies on poly(trimethylene terephthalate) filaments containing silver.” J Biomater Sci Polym Ed 15(12): 1545–59.
Agnihotri, S. A., N. N. Mallikarjuna, et al. (2004). “Recent advances on chitosan-based micro- and nanoparticles in drug delivery.” J Control Release 100(1): 5–28.
Balogh, L., D. R. Swanson, et al. (2001). “Dendrimer-silver complexes and nanocomposites as antimicrobial agents.” Nano Lett 1(1): 18–21.
Beyond Skin Science (2007). Corona, CA (March 20, 2007); http://www.beyondskinscience.com
Bhabak, K. P. and G. Mugesh (2007). “Synthesis, characterization, and antioxidant activity of some ebselen analogues.” Chem A Eur J 13(16): 4594–4601.
Bhadra, D., S. Bhadra, et al. (2003). “A PEGylated dendritic nanoparticulate carrier of fluorouracil.” Int J Pharm 257: 111–124.
Bhattacharya, S. and A. Bajaj (2005). “Recent advances in lipid molecular design.” Curr Opin Chem Biol 9(6): 647–655.
Bontha, S., A. V. Kabanov, et al. (2006). “Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs.” J Control Release 114(2): 163–74.
Borgia, S. L., Regehly, M., Sivaramakrishnan, R., Mehnert, W., Korting, H. C., Danker, K., Röder, B., Kramer, K. D. and Schäfer-Korting, M. (2005). “Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.” J Control Release, 110: 151–163.
Brannon-Peppas, L. (1995). “Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery.” Int J Pharm 116: 1–9.
Brannon-Peppas, L. and J. O. Blanchette (2004). “Nanoparticle and targeted systems for cancer therapy.” Adv Drug Del Rev 56: 1649–1659.
Brett, D. W. (2006). “A discussion of silver as an antimicrobial agent: alleviating the confusion.” Ostomy Wound Manage 52(1): 34–41.
Bromberg, L. E., D. K. Buxton, et al. (2001). “Novel periodontal drug delivery system for treatment of periodontitis.” J Control Release 71(3): 251–9.
Boutelet, K. and D. Candau (2006). Photoprotective/cosmetic compositions comprising sulfonic/hydrophobic amphiphilic polymers, USA, L' Oreal, Patent 7,045,120.
Calvo, P., J. L. VilaJato, et al. (1996). “Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.” J Pharm Sci 85(5): 530–536.
Caves, J. M. and E. L. Chaikof (2006). “The evolving impact of microfabrication and nanotechnology on stent design.” J Vasc Surg 44(6): 1363–1368.
Cengiz, E., Wissing, S. A., Müller, R. H. and Yazan, Y. (2006). Sunblocking efficiency of various ti)2-loaded solid lipid nanoparticle formulations. Int J Cosm Sci 28: 371–378.
Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H. and Yang, X. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release, 110: 296–306.
D'Emanuele, A. and D. Attwood (2005). “Dendrimer-drug interactions.” Adv Drug Del Rev 57(15): 2147–2162.
Devalapally, H., D. Shenoy, et al. (2007). “Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.” Cancer Chemo Pharmacol 59(4): 477–484.
Duprey Cosmetics (2007). (March 10, 2007); St. Pete Beach, Fl.; http://www.dupreycosmetics.com/ nano_dulcine.html
Edelman, E. R., L. Brown, et al. (1987). “In vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields.” J Biomed Mater Res 21(3): 339–53.
Edelman, E. R., A. Fiorino, et al. (1992). “Mechanical deformation of polymer matrix controlled release devices modulates drug release.” J Biomed Mater Res 26(12): 1619–31.
Environmental Working Group (2006). Washington, DC (October 10, 2006); http://www.ewg.org/issues/cosmetics/20061010/table2.php
Fonseca, C., S. Simões, et al. (2002). “Paclitaxel-loaded PLGA nanoparticles: preparation, physiochemical characterization and in vitro anti-tumoral activity.” J Control Release 83: 273–286.
Fresta, M., G. Puglisi, et al. (1995). “Pefloxacine mesilate-loaded and ofloxacin-loaded polyethylcyanoacrylate nanoparticles- Characterization of the colloidal drug carrier formulations.” J Pharm Sci 84(7): 895–902.
Fu, J., X. Li, et al. (2002). “Encapsulation of phthalocyanines in biodegradable poly(sebacic anhydride) nanoparticles.” Langmuir 18(10): 3843–3847.
Gaponik, N., I. L. Radtchenko, et al. (2004). “Luminescent polymer microcapsules addressable by a magnetic field.” Langmuir 20(4): 1449–52.
Georgakilas, V., K. Kordatos, et al. (2002). “Organic functionalization of carbon nanotubes.” J Am Chem Soc 124(5): 760–761.
Georgakilas, V., N. Tagmatarchis, et al. (2002). “Amino acid functionalization of water soluble carbon nanotubes.” Chem Communs 24: 3050–4051.
Guo, Z. and P. Sadler (1999). “Metals in medicine.” Angewandte Chemie-International Edition 38(11): 1513–1531.
Guzman, L. A., V. Labhasetwar, et al. (1996). “Local intraluminal infusion of biodegradable polymeric nanoparticles – A novel approach for prolonged drug delivery after balloon angioplasty.” Circulation 94(6): 1441–1448.
Handjani, R.-M. and Ribier, A. (2001). Compositions for the cosmetic and/or pharmaceutical treatment of the epidermis by topical application to the skin, and corresponding preparation process, USA, L' Oreal, Patent 6,203,802.
Hansenne, I. and Rick, D. W. (2002). High SPF nontacky/nongreasy uv-photoprotecting compositions comprising particulates of MMA crosspolymers, USA, L' Oreal, Patent 6,432,389.
Heller, J., J. Barr, et al. (2002). “Poly(ortho esters): synthesis, characterization, properties and uses.” Adv Drug Del Rev 54(7): 1015–1039.
Hirsch, L. R., A. M. Gobin, et al. (2006). “Metal nanoshells.” Ann Biomed Eng 34(1): 15–22.
Horcajada, P., C. Marquez-Alvarez, et al. (2006). “Controlled release of ibuprofen from dealuminated faujasites ” Solid State Sciences 8(12): 1459–1465
Horcajada, P., C. Serre, et al. (2006). “Metal-organic frameworks as efficient materials for drug delivery.” Angew Chem Int Ed Engl 45(36): 5974–8.
Hu, Y. X., J. Chang, et al. (2005). Preparation and evaluation of 5-FU/PLGA/gene nanoparticles. Asbm6: Advanced Biomaterials Vi. Zurich-Uetikon, Trans Tech Publications Ltd: 147–150.
Huth, S., J. Lausier, et al. (2004). “Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer.” J Gene Med 6(8): 923–36.
Isab, A. A. and M. I. Wazeer (2007). “Synthesis and characterization of thiolate-Ag(I) complexes by solid-state and solution NMR and their antimicrobial activity.” Spectrochim Acta A Mol Biomol Spectrosc 66(2): 364–370.
Jain, R. A. (2000). “The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.” Biomaterials 21(23): 2475–2490.
Jee, J.-P., Lim, S.-J., Park, J.-S. and Kim, C.-K. (2006). “Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.” Eur J Pharm Biopharm, 63: 134–139.
Jenning, V., Gysler, A., Schäfer-Korting, M. and Gohla, S. H. (2000). “Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting in the upper skin.” Eur J Pharm Biopharm, 49: 211–218.
Kam, N. W. and H. Dai (2005). “Carbon nanotubes as intracellular protein transporters: generally and biological functionality.” J Am Chem Soc 127(16): 6021–6026.
Karlov, A. V., I. A. Khlusov, et al. (2002). “Adhesion of Staphylococcus aureus to implants with different physicochemical characteristics.” Bull Exp Biol Med 134(3): 277–80.
Kost, J., R. Noecker, et al. (1985). “Magnetically controlled release systems: effect of polymer composition.” J Biomed Mater Res 19(8): 935–40.
Kost, J., J. Wolfrum, et al. (1987). “Magnetically enhanced insulin release in diabetic rats.” J Biomed Mater Res 21(12): 1367–73.
Kumar, R., S. Howdle, et al. (2005). “Polyamide/silver antimicrobials: effect of filler types on the silver ion release.” J Biomed Mater Res B Appl Biomater 75(2): 311–9.
Labhasetwar, V., C. X. Song, et al. (1998). “Arterial uptake of biodegradable nanoparticles: Effect of surface modifications.” J Pharm Sci 87(10): 1229–1234.
Lanza, G. M., X. Yu, et al. (2002). “Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis.” Circulation 106(22): 2842–2847.
Li, Y.-Y., X.-Z. Zhang, et al. (2006). “Novel stimuli-responsive micelle self-assembled from Y-shaped P(UA-Y-NIPAAm) copolymer for drug delivery.” Biomacromolecules 7(11): 2956–2960.
Lin, A. W., N. A. Lewinski, et al. (2005). “Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells.” J Biomed Opt 10(6): 064035.
Liu, J., Hu, W., Chen, H., Ni, Q., Xu, H. and Yang, X. (2007). “Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.” Int J Pharm, 328: 191–195.
Liu, M. J., K. Kono, et al. (2000). “Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents.” J Control Release 65(1–2): 121–131.
Lu, Z., J. Z. Bei, et al. (1999). “A method for the preparation of polymeric nanocapsules without stabilizer.” J Control Release 61(1–2): 107–112.
MacLachlan, M., I. Manners, et al. (2000). “New (inter)faces: Polymers and inorganic materials ” Adv Materials 12(9): 675–681.
Mainardes, R. M. and L. P. Silva (2004). “Drug delivery systems: Past, present, and future.” Curr Drug Targets 5(5): 449–455.
Mitra, S., U. Gaur, et al. (2001). “Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.” J Control Release 74: 317–323.
Muller, R. H., K. Mader, et al. (2000). “Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art.” Eur J Pharm Biopharm 50(1): 161–177.
Müller, R. H., Radtke, M. and Wissing, S. A. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Del Rev, 54: S131–S155.
Nakayama, M., T. Okano, et al. (2006). “Molecular design of biodegradable polymeric micelles for temperature-responsive drug release.” J Control Release 115(1): 46–56.
Napoli, A., M. Valentini, et al. (2005). “Oxidation-responsive polymeric vesicles.” Nature Biomaterials 3(3): 183–189.
Niwa, T., H. Takeuchi, et al. (1993). “Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior.” J Control Release 25: 89–93.
O'Reilly, R. K., C. J. Hawker, et al. (2006). “Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.” Chemical Society Reviews 35(11): 1068–1083.
Oh, K. T., T. K. Bronich, et al. (2006). “Block ionomer complexes as prospective nanocontainers for drug delivery.” J Control Release 115(1): 9–17.
Owens III, D. and N. Peppas (2006). “Integration of thermally responsive nanosphere hydrogels with gold nanoparticles for intelligent therapeutic applications.” Trans Soc Biomater 31: 150–151.
Panyam, J., W.-Z. Zhou, et al. (2002). “Rapid endo-lysosomal escape of poly(D,L-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery.” FASEB 16(10): 1217–1226.
Pastorin, G., W. Wu, et al. (2006). “Double functionalization of carbon nanotubes for multimodal delivery.” Chem Commun 11: 1182–1184.
Patton, J. N. and A. F. Palmer (2005). “Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier.” Biomacromolecules 6(4): 2204–2212.
Plank, C., F. Scherer, et al. (2003). “Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields.” J Liposome Res 13(1): 29–32.
Plank, C., U. Schillinger, et al. (2003). “The magnetofection method: using magnetic force to enhance gene delivery.” Biol Chem 384(5): 737–47.
Potineni, A., D. M. Lynn, et al. (2003). “Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.” J Control Release 86(2–3): 223–234.
Radwan, M. A. (1995). “In-vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug carrier for theophylline.” Drug Dev Ind Pharm 21(20): 2371–2375.
Rehor, A., J. A. Hubbell, et al. (2005). “Oxidation-sensitive polymeric nanoparticles.” Langmuir 21(1): 411–417.
Rhim, J. W., S. I. Hong, et al. (2006). “Preparation and characterization of chitosan-based nanocomposite films with antimicrobial activity.” J Agric Food Chem 54(16): 5814–22.
Roskos, K. V., B. K. Fritzinger, et al. (1995). “Development of a drug-delivery system for the treatment of periodontal-disease based on bioerodible poly(ortho esters).” Biomaterials 16(4): 313–317.
Sajeesh, S. and C. P. Sharma (2005). “Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.” J Biomat Mater Res B: Appl Biomat 76B(2): 298–305.
Sakurai, H., A. Katoh, et al. (2006). “Chemistry and biochemistry of insulin-mimetic vanadium and zinc complexes. Trial for treatment of diabetes mellitus.” Bull. Chem. Soc. Jpn. 79(11): 1645–1664
Sambhy, V., M. M. MacBride, et al. (2006). “Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials.” J Am Chem Soc 128(30): 9798–808.
Sawant, R. M., J. P. Hurley, et al. (2006). ““SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.” Bioconjug Chem 17(4): 943–949.
Schierholz, J. M., L. J. Lucas, et al. (1998). “Efficacy of silver-coated medical devices.” J Hosp Infect 40(4): 257–62.
Schmaljohann, D. (2006). “Thermo- and pH-responsive polymers in drug delivery.” Adv Drug Del Rev 58(15): 1655–1670.
Sershen, S. R., S. L. Westcott, et al. (2000). “Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery.” J Biomed Mater Res 51(3): 293–8.
Seymour, L. W., R. Duncan, et al. (1994). “Poly(ortho ester) matrices for controlled release of the antitumor agent 5-fluorouracil.” J Control Release 31: 201–206.
Shenoy, D., S. Little, et al. (2005). “Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. Part 1 In vitro evaluations.” Mol Pharmacy 2(5): 357–366.
Shenoy, D., S. Little, et al. (2005). “Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies.” Pharm Res 22(12): 2107–2114.
Shikata, F., H. Tokumitsu, et al. (2002). “In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.” Eur. J. Pharm Biopharm. 53: 57–63.
Simonnet, J.-T. and Richart, P. (2002). Nanocapsules based on dendritic polymers, USA, L' Oreal, Patent 6,379,683.
Simonnet, J.-T., Richart, P. and Biatry, B. (2003). Nanocapsules based on poly(alkylene adipate), process for their preparation and cosmetic or dermatological compositions containing them, USA, L' Oreal, Patent 6,565,886.
Singh, R., D. Pantarotto, et al. (2006). “Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.” PNAS 103(9): 3357–3362.
Smaihi, M., E. Gavilan, et al. (2004). “Colloidal functionalized calcined zeolite nanocrystals ” J Mater Chem 14(8): 1347–1351.
Song, C. and Liu, S. (2005). “A new healthy sunscreen system for humans: Solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding vitamin E.” Int J Bio Macromol, 36: 116–119.
Soppimath, K. S. and T. M. Aminabhavi (2002). “Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type.” J Microencapsulation 19(3): 281–292.
Soppimath, K. S., T. M. Aminabhavi, et al. (2001). “Biodegradable polymeric nanoparticles as drug delivery devices.” J Controlled Release 70(1–2): 1–20.
Soppimath, K. S., D. C.-W. Tan, et al. (2005). “pH-Triggered thermally responsive polymer core-shell nanoparticles for drug delivery.” Adv Mater 17(3): 318–323.
Steinbrink, J., H. Wabnitz, et al. (2001). “Determining changes in NIR absorption using a layered model of the human head.” Phys Med Biol 46(3): 879–896.
Taha, E. I., Samy, A. M., Kassem, A. A. and Khan, M. A. (2005). Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm Dev Tech, 10: 363–370.
Tirelli, N. (2006). “(Bio)responsive nanoparticles.” Curr Opin Colloidal & Interface Sci 11(4): 210–216.
Tokumitsu, H., H. Ichikawa, et al. (1999). “Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: Preparation by novel emulsion-droplet coalescence technique and characterization.” Pharm Res 16(12): 1830–1835.
Uhrich, K. E., S. M. Cannizzaro, et al. (1999). “Polymeric systems for controlled drug release.” Chem Rev 99(11): 3181–3198.
van Zutphen, S. and J. Reedijk (2005). “Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity.” Coordination Chem Rev 249(24): 2845–2853.
Vaupel, P., F. Kallinowski, et al. (1989). “Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review.” Cancer Res 49(23): 6449–6465.
Verma, A. K., K. Sachin, et al. (2005). “Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor - Cycloheximide, for possible therapeutic applications.” Curr Pharm Biotechnol 6(2): 121–130.
Wei, H., X.-Z. Zhang, et al. (2006). “Self-assembled thermo- and pH-responsive micelles of poly(10-undecenoic acid-b-N-isopropylacrylamide) for drug delivery.” J Control Release 116(3): 266–274.
Wike-Hooley, J. A., J. Haveman, et al. (1984). “The relevance of tumor pH to the treatment of malignant disease.” Radiother Oncol 2(4): 343–366.
Wissing, S. A. and Müller, R. H. (2003). “Cosmetic applications for solid lipid nanoparticles (SLN).” Int J Pharm, 254, 65–68.
Wojtowicz, H., K. Kloc, et al. (2004). “Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties.” Farmaco 59(11): 863–8.
Wu, W., S. Wieckowski, et al. (2005). “Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes.” Angew. Chem. Int. Ed. 44(39): 6358–6362.
Xu, P., E. A. Van Kirk, et al. (2006). “Anticancer Efficacies of Cisplatin-Releasing pH-Responsive Nanoparticles.” Biomacromolecules 7(3): 829–835.
Yoo, H. S., K. H. Lee, et al. (2000). “In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates.” J Control Release 68(3): 419–431.
Zhang, H., Y. Kim, et al. (2006). “Controlled release of paraquat from surface-modified zeolite Y.” Microporous and Mesoporous Materials 88(1–3): 312–318
Zwiorek, K., J. Kloeckner, et al. (2004). “Gelatin nanoparticles as a new and simple gene delivery system.” J Pharm Pharmac Sci 7(4): 22–28.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Betancourt, T., Doiron, A., Homan, K.A., Brannon-Peppas, L. (2009). Controlled Release and Nanotechnology. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-77668-2_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77667-5
Online ISBN: 978-0-387-77668-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)